ESC Premium Access

Titration patterns and clinical characteristics of patients prescribed sacubitril/valsartan in the primary care and cardiology settings in germany

Congress Session

About the speaker

Associate Professor Rolf Wachter

University hospital Leipzig AoR, Leipzig (Germany)
7 presentations
0 follower

7 more presentations in this session

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Speaker: Doctor T. Noto (Sapporo, JP)

Thumbnail

Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus.

Speaker: Professor C. Lang (Dundee, GB)

Thumbnail

Diminished response to statin therapy predicts future occurrence of heart failure in patients with acute myocardial infarction

Speaker: Doctor K. Tsuda (Takatsuki, JP)

Thumbnail

Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

Heart rate reduction by selective sinus node blocker (ivabradine) protects against detrimental hemodynamic and structural effects of iv inotrops in heart failure

Speaker: Professor P. Leszek (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 1 - Chronic heart failure – Treatment

Speakers: Associate Professor R. Wachter, Doctor T. Noto, Professor C. Lang, Doctor K. Tsuda, Professor U. Zeymer...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk